Dr Fanning received the AACR-AstraZeneca research award at a recent AACR special conference focused on prostate cancer in San Diego, California. Prostate cancer is the most common cancer among men in the developed world. Over 2,200 Irish men, north and south of the island will be diagnosed with the disease this year.
No single biomarker exists that can accurately diagnose the presence of prostate cancer, identify the extent of the disease and predict how it will progress in an individual patient. Contemporary prostate cancer research is turning to identifying a panel of protein biomarkers that can act as a prognostic tool in parallel to clinical evaluation.
Commenting on the award, Professor Watson added, “This novel panel of markers were identified from our multi-disciplinary approach to biomarker discovery at UCD Conway Institute, which has recently been published. The current validation study is an important step to bring these markers to clinical utilisation. In collaboration with our current international consortium partners in Austria, Australia and the US, we will now bring these markers into an international validation study”
Dr Fanning is undertaking her MD within the research group led by Conway Fellow, Professor R. William G. Watson as part of the Prostate Cancer Research Consortium (PCRC), an initiative established under Molecular Medicine Ireland to improve the detection, prognosis and treatment of the disease. This research is being funded through the Irish Cancer Society.
Elaine Quinn | alfa
Mass spectrometry sheds new light on thallium poisoning cold case
14.12.2018 | University of Maryland
Protein involved in nematode stress response identified
14.12.2018 | University of Illinois College of Agricultural, Consumer and Environmental Sciences
The more objects we make "smart," from watches to entire buildings, the greater the need for these devices to store and retrieve massive amounts of data quickly without consuming too much power.
Millions of new memory cells could be part of a computer chip and provide that speed and energy savings, thanks to the discovery of a previously unobserved...
What if, instead of turning up the thermostat, you could warm up with high-tech, flexible patches sewn into your clothes - while significantly reducing your...
A widely used diabetes medication combined with an antihypertensive drug specifically inhibits tumor growth – this was discovered by researchers from the University of Basel’s Biozentrum two years ago. In a follow-up study, recently published in “Cell Reports”, the scientists report that this drug cocktail induces cancer cell death by switching off their energy supply.
The widely used anti-diabetes drug metformin not only reduces blood sugar but also has an anti-cancer effect. However, the metformin dose commonly used in the...
A research team from the University of Zurich has developed a new drone that can retract its propeller arms in flight and make itself small to fit through narrow gaps and holes. This is particularly useful when searching for victims of natural disasters.
Inspecting a damaged building after an earthquake or during a fire is exactly the kind of job that human rescuers would like drones to do for them. A flying...
Over the last decade, there has been much excitement about the discovery, recognised by the Nobel Prize in Physics only two years ago, that there are two types...
12.12.2018 | Event News
10.12.2018 | Event News
06.12.2018 | Event News
14.12.2018 | Power and Electrical Engineering
14.12.2018 | Physics and Astronomy
14.12.2018 | Physics and Astronomy